Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Have Never Been This Bullish On Cardlytics, Inc. (CDLX)

How do we determine whether Cardlytics, Inc. (NASDAQ:CDLX) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that their consensus long positions have historically outperformed the market when we adjust for known risk factors.

Is Cardlytics, Inc. (NASDAQ:CDLX) the right pick for your portfolio? Investors who are in the know are buying. The number of bullish hedge fund positions advanced by 1 recently. Our calculations also showed that CDLX isn’t among the 30 most popular stocks among hedge funds (see the video below). CDLX was in 10 hedge funds’ portfolios at the end of the second quarter of 2019. There were 9 hedge funds in our database with CDLX holdings at the end of the previous quarter.
5 Most Popular Stocks Among Hedge Funds
Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

At the moment there are a large number of formulas market participants put to use to analyze publicly traded companies. A pair of the less known formulas are hedge fund and insider trading moves. We have shown that, historically, those who follow the top picks of the top money managers can trounce the S&P 500 by a healthy amount (see the details here).


Unlike former hedge manager, Dr. Steve Sjuggerud, who is convinced Dow will soar past 40000, our long-short investment strategy doesn’t rely on bull markets to deliver double digit returns. We only rely on hedge fund buy/sell signals. Let’s take a gander at the key hedge fund action regarding Cardlytics, Inc. (NASDAQ:CDLX).

How are hedge funds trading Cardlytics, Inc. (NASDAQ:CDLX)?

At the end of the second quarter, a total of 10 of the hedge funds tracked by Insider Monkey were long this stock, a change of 11% from one quarter earlier. The graph below displays the number of hedge funds with bullish position in CDLX over the last 16 quarters. So, let’s check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

Carlo Cannell

More specifically, CAS Investment Partners was the largest shareholder of Cardlytics, Inc. (NASDAQ:CDLX), with a stake worth $56.2 million reported as of the end of March. Trailing CAS Investment Partners was Cannell Capital, which amassed a stake valued at $16.3 million. Shannon River Fund Management, Driehaus Capital, and Antipodean Advisors were also very fond of the stock, giving the stock large weights in their portfolios.

Now, key money managers have jumped into Cardlytics, Inc. (NASDAQ:CDLX) headfirst. CAS Investment Partners, managed by Clifford A. Sosin, created the biggest position in Cardlytics, Inc. (NASDAQ:CDLX). CAS Investment Partners had $56.2 million invested in the company at the end of the quarter. Richard Driehaus’s Driehaus Capital also made a $6.4 million investment in the stock during the quarter. The following funds were also among the new CDLX investors: Eric Chen’s Antipodean Advisors, Ari Zweiman’s 683 Capital Partners, and Israel Englander’s Millennium Management.

Let’s check out hedge fund activity in other stocks similar to Cardlytics, Inc. (NASDAQ:CDLX). These stocks are Precision BioSciences, Inc. (NASDAQ:DTIL), Live Oak Bancshares Inc (NASDAQ:LOB), Retail Value Inc. (NYSE:RVI), and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX). All of these stocks’ market caps are closest to CDLX’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
DTIL 9 64292 -5
LOB 6 33226 -4
RVI 17 78786 0
LXRX 11 18702 -1
Average 10.75 48752 -2.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 10.75 hedge funds with bullish positions and the average amount invested in these stocks was $49 million. That figure was $103 million in CDLX’s case. Retail Value Inc. (NYSE:RVI) is the most popular stock in this table. On the other hand Live Oak Bancshares Inc (NASDAQ:LOB) is the least popular one with only 6 bullish hedge fund positions. Cardlytics, Inc. (NASDAQ:CDLX) is not the least popular stock in this group but hedge fund interest is still below average. Our calculations showed that top 20 most popular stocks among hedge funds returned 24.4% in 2019 through September 30th and outperformed the S&P 500 ETF (SPY) by 4 percentage points. A small number of hedge funds were also right about betting on CDLX as the stock returned 29% during the same time frame and outperformed the market by an even larger margin.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.